This article explains, in educational terms, peripheral stenting — how the technology works and where it fits. Symptoms range from exertional leg pain (claudication) to, in severe cases, rest pain and non-healing wounds known as critical limb ischemia. As a medical device manufacturer, INVAMED develops technologies in this area; the information here is educational and not medical advice.
Background: Peripheral Arterial Disease (PAD)
Atherectomy removes or modifies plaque, which can be useful in heavily calcified lesions before ballooning or stenting. Percutaneous transluminal angioplasty (PTA) uses a balloon to widen the artery, and drug-coated balloons add an antiproliferative agent to limit re-narrowing. Device selection depends on lesion location, length, calcification, and clinical presentation, and is decided by the vascular specialist.
Peripheral Stenting
Peripheral stents scaffold an artery open after angioplasty when the vessel recoils or dissects, maintaining the widened lumen. Self-expanding nitinol stents are common in mobile segments like the femoropopliteal artery. Covered stent grafts can be used to exclude certain lesions or manage complications. INVAMED's Atlas peripheral stent graft addresses covered-stent applications in the PAD portfolio.
Design and Technical Notes
INVAMED's PAD portfolio spans access, plaque modification, angioplasty, drug delivery, stenting, and embolic protection. Embolic protection is often paired with atherectomy to capture dislodged debris. INVAMED PAD devices are for use by trained vascular specialists per the IFU and local approvals.
Key Considerations
- Lesion calcification is a major factor in choosing between plain angioplasty, atherectomy, drug delivery, and stenting.
- Manufacturer figures reflect studied device performance, not guaranteed outcomes.
- Embolic protection is often paired with atherectomy to capture dislodged debris.
Frequently Asked Questions
Are these devices CE marked?
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.
Who decides which PAD device to use?
A vascular specialist selects devices based on lesion characteristics; this content is educational and not a treatment recommendation.
Does INVAMED make a drug-coated balloon?
Yes. The Extender paclitaxel drug-coated balloon is INVAMED's peripheral drug-delivery balloon.
Clinical and Technical Context
INVAMED's Guardian protection device is designed for this distal-capture role. Device selection depends on lesion location, length, calcification, and clinical presentation, and is decided by the vascular specialist. INVAMED's Extender paclitaxel drug-coated balloon is positioned for this drug-delivery role in peripheral vessels. Use is guided by lesion morphology and clinician preference. Peripheral arterial disease is the narrowing of arteries outside the heart — most often in the legs — due to atherosclerotic plaque, reducing blood flow to the limbs. INVAMED's Invaducer introducer sheath sets support the access step of peripheral interventions. Access sheath sizing should match the planned devices to limit access-site complications. Manufacturer figures reflect studied device performance, not guaranteed outcomes. Drug dose and balloon sizing follow the device specifications and lesion characteristics. Femoropopliteal segments favor flexible self-expanding devices because of repeated flexion. Percutaneous transluminal angioplasty (PTA) uses a balloon to widen the artery, and drug-coated balloons add an antiproliferative agent to limit re-narrowing. Endovascular therapy aims to restore flow through the narrowed segment using balloons, stents, atherectomy, or a combination. Atherectomy removes or modifies plaque, which can be useful in heavily calcified lesions before ballooning or stenting. Symptoms range from exertional leg pain (claudication) to, in severe cases, rest pain and non-healing wounds known as critical limb ischemia. Atherectomy is often paired with embolic protection to capture dislodged debris. Appropriate access selection helps reduce access-site complications. Balloon diameter and length are matched to the vessel to avoid over- or under-dilation. Embolic protection is often paired with atherectomy to capture dislodged debris. Covered stent grafts can be used to exclude certain lesions or manage complications. INVAMED's TemREN atherectomy system is positioned for peripheral plaque modification.
Related on INVAMED
- Peripheral Arterial Disease (PAD) — product category
- Embolic Protection: How It Works and Why It Matters
- How long does a leg stent last?
- Inside the Guardian Protection Device: Design and Applications
Important Disclaimer
This content is educational and technical in nature and must not be interpreted as medical advice or as a promise of any clinical outcome. Individual results depend on many factors and can only be evaluated by a treating physician. Figures attributed to INVAMED reflect manufacturer or published data and are not a guarantee of results. All INVAMED devices are to be used by trained clinicians per the approved IFU, and availability is subject to local regulatory status.
Reviewed by the INVAMED Medical Affairs team. Content is educational and technical in nature.